CEO of Moderna: Coronavirus vaccine pricing may start at $25 and do not pursue maximum profits
On November 22, according to several foreign media reports, Stephanne Bancel, CEO of the American biotechnology company Moderna, said that the government is seeking to order a potential coronavirus vaccine for Modena at a price per dose or 25. Between USD and USD 37, depending on the amount you order.
Bonnell stressed that Moderna is not pursuing the maximum profit on the coronavirus vaccine.
It is worth mentioning that according to the Financial Times on July 28, Moderna plans to sell the coronavirus vaccine under development for $50 to $60 per two doses (one course of treatment). Calculated according to the price of a single dose, the price disclosed by Nabonser this time is basically the same as previous foreign media reports.
On November 16th local time, Moderna, an American biotechnology company, announced that it was 94.5% efficient in developing the coronavirus vaccine mRNA-1273 and planned to apply to the United States for emergency use of the coronavirus vaccine in the next few weeks.
It is reported that by the end of 2020, Moderna is expected to ship about 20 million doses of mRNA-1273 in the United States and is expected to produce 500 million to 1 billion doses worldwide by 2021.
